Chesapeake Wealth Management’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $3.64M | Sell |
3,031
-111
| -4% | -$113K | 1.02% | 24 |
|
|
2026
Q1 | $2.89M | Sell |
3,142
-161
| -5% | -$163K | 0.89% | 32 |
|
|
2025
Q4 | $3.55M | Buy |
3,303
+143
| +5% | +$137K | 1.06% | 26 |
|
|
2025
Q3 | $2.41M | Buy |
3,160
+65
| +2% | +$48.4K | 0.74% | 41 |
|
|
2025
Q2 | $2.41M | Sell |
3,095
-45
| -1% | -$35K | 0.8% | 40 |
|
|
2025
Q1 | $2.59M | Sell |
3,140
-113
| -3% | -$94K | 0.93% | 32 |
|
|
2024
Q4 | $2.51M | Sell |
3,253
-177
| -5% | -$147K | 0.86% | 37 |
|
|
2024
Q3 | $3.04M | Sell |
3,430
-107
| -3% | -$96.2K | 1.04% | 27 |
|
|
2024
Q2 | $3.2M | Sell |
3,537
-135
| -4% | -$108K | 1.16% | 23 |
|
|
2024
Q1 | $2.86M | Sell |
3,672
-509
| -12% | -$362K | 1.04% | 30 |
|
|
2023
Q4 | $2.44M | Sell |
4,181
-236
| -5% | -$138K | 0.94% | 33 |
|
|
2023
Q3 | $2.37M | Sell |
4,417
-283
| -6% | -$146K | 0.99% | 29 |
|
|
2023
Q2 | $2.2M | Sell |
4,700
-59
| -1% | -$24.7K | 0.87% | 37 |
|
|
2023
Q1 | $1.63M | Sell |
4,759
-79
| -2% | -$26.6K | 0.68% | 46 |
|
|
2022
Q4 | $1.77M | Sell |
4,838
-198
| -4% | -$70.2K | 0.78% | 38 |
|
|
2022
Q3 | $1.63M | Sell |
5,036
-258
| -5% | -$81.7K | 0.74% | 37 |
|
|
2022
Q2 | $1.72M | Sell |
5,294
-66
| -1% | -$19.8K | 0.73% | 38 |
|
|
2022
Q1 | $1.53M | Sell |
5,360
-333
| -6% | -$85.7K | 0.56% | 45 |
|
|
2021
Q4 | $1.57M | Sell |
5,693
-180
| -3% | -$45.6K | 0.53% | 49 |
|
|
2021
Q3 | $1.36M | Sell |
5,873
-685
| -10% | -$169K | 0.49% | 55 |
|
|
2021
Q2 | $1.51M | Sell |
6,558
-743
| -10% | -$149K | 0.49% | 51 |
|
|
2021
Q1 | $1.36M | Sell |
7,301
-385
| -5% | -$75.3K | 0.46% | 59 |
|
|
2020
Q4 | $1.3M | Sell |
7,686
-329
| -4% | -$49.1K | 0.44% | 65 |
|
|
2020
Q3 | $1.19M | Sell |
8,015
-5
| -0.1% | -$774 | 0.44% | 67 |
|
|
2020
Q2 | $1.32M | Buy |
8,020
+58
| +0.7% | +$8.9K | 0.52% | 53 |
|
|
2020
Q1 | $1.1M | Sell |
7,962
-17
| -0.2% | -$2.34K | 0.51% | 57 |
|
|
2019
Q4 | $1.05M | Sell |
7,979
-2,164
| -21% | -$251K | 0.4% | 78 |
|
|
2019
Q3 | $1.13M | Sell |
10,143
-6,512
| -39% | -$725K | 0.46% | 68 |
|
|
2019
Q2 | $1.84M | Buy |
16,655
+1,935
| +13% | +$228K | 0.77% | 31 |
|
|
2019
Q1 | $1.91M | Buy |
14,720
+3,297
| +29% | +$401K | 0.84% | 23 |
|
|
2018
Q4 | $1.32M | Buy |
11,423
+2,510
| +28% | +$280K | 0.65% | 38 |
|
|
2018
Q3 | $957K | Sell |
8,913
-149
| -2% | -$14.9K | 0.43% | 65 |
|
|
2018
Q2 | $774K | Sell |
9,062
-381
| -4% | -$31.3K | 0.36% | 76 |
|
|
2018
Q1 | $730K | Buy |
+9,443
| New | +$760K | 0.34% | 81 |
|
Other funds holding LLY
Chesapeake Wealth Management's LLY Position: Q2 2026 in Review
Chesapeake Wealth Management reduced its Eli Lilly (LLY) stake by 3.5% in Q2 2026, selling an estimated $113K and leaving 3,031 shares worth $3.64M. The position accounts for 1.02% of the portfolio, ranked #24.
Chesapeake Wealth Management first reported a position in LLY in Q1 2018 and has held it in 34 quarters since. 4,642 funds tracked by Wall St. Rank hold LLY as of Q2 2026.
- Chesapeake Wealth Management held 3,031 shares of Eli Lilly worth $3.64M as of Q2 2026.
- Chesapeake Wealth Management sold 111 Eli Lilly shares in Q2 2026, an estimated $113K.
- Eli Lilly made up 1.02% of Chesapeake Wealth Management's portfolio in Q2 2026, its #24 holding.
- Chesapeake Wealth Management first reported a position in Eli Lilly in Q1 2018 and has held it in 34 quarters since.
- 4,642 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.
Based on Chesapeake Wealth Management's 13F filing for Q2 2026, filed 13 Aug 2026.